CIK 0000926617
- Non-accelerated filer
- Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330595156
- Phone
- +1 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 15,680 shares (grant or award)
- 4 Grant or award Director acquired 16,442 shares (grant or award)
- 4 Grant or award Director acquired 4,031 shares (grant or award)
- 4 Grant or award Director acquired 9,205 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 50,000 shares at $2.78 ($139,000)
- 4 Insider Changes in Ownership
- 4 Open-market buy 10% owner bought 2,285,715 shares at $3.50 ($8,000,003)
- 4 Option exercise 10% owner acquired 730,560 shares (option exercise)
- 4 Option exercise 10% owner acquired 463,298 shares (option exercise)
- 4/A Option exercise Director acquired 5,021 shares (option exercise)
- 4 Option exercise President and CEO acquired 7,531 shares (option exercise)
- 4 Option exercise Director acquired 11,250 shares (option exercise)
- 4 Option exercise Director acquired 5,021 shares (option exercise)
- 4 Option exercise Director acquired 5,210 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 10 of 28 · 551 filings